Ivan Ivanov

Ivan Ivanov is a scientist II, editor of development at Verve Therapeutics. Mr. Ivanov has more than 10 years of experience in biotechnology, nanotechnology, drug discovery, molecular biology, and assay development. Prior to joining Verve, he worked as a scientist at CRISPR Therapeutics, where he supported the hematology and in-vivo programs. He received his B.S. in Biology, from Northeastern University.